Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
Transactions under Novozymes’ stock buyback program
Please read the full announcement in the attached PDF
Attachment
2018_48_Stock_Buybackprogram_EN
Monday, August 13, 2018 - 08:02
Related Stories
Transactions under Novozymes’ stock buyback program
August 6, 2018
Transactions under Novozymes’ stock buyback program
August 20, 2018
Transactions under Novozymes’ stock buyback program
August 27, 2018
Transactions under Novozymes’ stock buyback program
May 7, 2018
Transactions under Novozymes’ stock buyback program
May 14, 2018